Merz, Maximilian
Dechow, Tobias
Scheytt, Mithun
Schmidt, Christian
Hackanson, Bjoern
Knop, Stefan
Funding for this research was provided by:
Julius-Maximilians-Universität Würzburg
Article History
Received: 31 July 2019
Accepted: 4 April 2020
First Online: 16 April 2020
Compliance with ethical standards
:
: MM has received consultancy fees from Amgen and Takeda, research support from Takeda, and travel grants from Abbvie, Amgen, Takeda, and Celgene. CS has served on advisory councils/committees for Kite Gilead and Novartis, and received honoraria from Roche, Novartis, and Kite Gilead, and research support from Janssen. BH has served on advisory councils/committees for Boehringer Ingelheim, Roche, BMS, Novartis, and Abbvie. SK has received consultancy fees from Bristol-Myers Squibb, Amgen, Celgene, and Oncopeptides; served on advisory councils/committees for Bristol-Myers Squibb, Amgen, Celgene, and Oncopeptides; and received honoraria from Bristol-Myers Squibb, Amgen, Celgene, Janssen, and Oncopeptides. TD and MS declare that they have no conflict of interest.